Sentosa SQ Leukemia Panel

Detect sequence variants in leukemia samples

(Early Access Available)


The Sentosa® SQ Leukemia Panel is a DNA-based Next Generation Sequencing (NGS) assay that identifies gene mutations including single-nucleotide variants (SNVs) and insertions and deletions (indels) on a single platform. The panel is designed to detect approximately 3,312 mutations in 49 key cancer genes.  The genes selected for this panel include targets associated with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and myeloproliferative neoplasms (MPN) as well as ALL, CML, and CLL.

The highly automated Sentosa® SQ NGS workflow with Sentosa® SQ Leukemia Panel begins from the extraction of peripheral blood samples, to the generation of reports within 2.5 days .  This workflow requires less than 3.5 hours of hands-on time. 


For more information on the genes and target mutations, please contact authorized Vela Diagnostics representatives.


Supporting Decision-Making:

  • Automated and user-friendly results interpretation with Sentosa SQ Reporter

Providing Laboratory Efficiency:

  • From sample to result in 2.5 days
  • Seamless sample traceability and IT connectivity with Sentosa Link


Sample Input Peripheral Blood Samples
Target Genes 49
Target Amplicons 287
Target Mutations 3,312
Hands-on Time ≤ 3.5 hours
Turn-around Time ≤ 2.5 days


ProductPack SizeItem Number
Sentosa SQ Leukemia Panel - Early Access Available 4x8 690030
Sentosa SX Whole Blood Kit 4x8 300251
Sentosa SX101 1 400089
Sentosa ST Template Kit 8 runs 690007
Sentosa SQ Sequencing Kit 8 runs 690005
Sentosa SQ 318 Chip Kit 8 runs 300301
Sentosa ST401 1 690027
Sentosa SQ301 (120 VAC) 1 690026
Sentosa SQ301 (230 VAC) 1 690025